BACKGROUND: The increased prevalence of cancer and the negative impact of pain on the quality of life of patients underscore the need to implement efficient palliative care interventions and management of pain. The cost-effectiveness of palliative care interventions for cancer, mostly pharmacological and delivered through home-based palliative care services, is unclear. Most of the studies do not take into account indirect costs nor consider variations across different geographical regions. OBJECTIVE: To describe existing and cutting-edge knowledge on cost-effectiveness or item costs related to palliative home-based care for patients with cancer. We evaluated various costs, including direct medical, non-medical, and indirect costs in different geographical regions and analysed how different options for care affect the patients' quality of life and associated expenses. METHODS: This Prospero-registered systematic review (CRD42023404217) adhered to the PRISMA criteria. Following a multistep selection process, we selected 22 articles published between 2013 and 2023 focused on quality of life outcomes and cost-effectiveness of home-based palliative care for cancer patients. RESULTS: Home-based palliative care decreases the number of hospital visits, while its influence on patients quality of life is currently difficult to demonstrate across geographic regions based on available evidence. Overall, home care decreases the costs associated to the palliative care of patients with cancer. The cost structure analysis revealed that besides healthcare costs, informal care expenses and productivity losses represent a significant proportion of overall expenses). In Europe, the direct medical, non-medical, and indirect costs (in purchasing power parity) were on average $1,941, $842, and $1,241, per month per person, respectively. In the USA and Asia, direct medical and indirect costs are on average $1,095 (USA) vs $1,444 (Asia) and $2,192 (USA) vs $1,162 (Asia). CONCLUSION: In conclusion, the studies reviewed highlight significant cost variations and potential savings associated with palliative home-based care for cancer patients. Home-based palliative care, particularly involving medications, has shown favorable cost-effectiveness compared to hospital care. Specialized palliative home care, psychological interventions, and outpatient services further contribute to overall cost savings. However, the economic impact varies across different geographical contexts and cost categories, emphasizing the need for tailored approaches in palliative care planning and implementation.

Betthera S r o Hradec Kralove Czech Republic

Prague University of Economics and Business Faculty of Management Department of Management Prague Czech Republic

University of Hradec Kralove Faculty of Informatics and Management Department of Economics Hradec Kralove Czech Republic

University of Santiago de Compostela Department of Clinical Psychology and Psychobiology A Coruña Spain

Zobrazit více v PubMed

The University of Texas MD Anderson Cancer Center Cancer Pain Management. Available from: https://www.mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/cancer-pain-management.html. Accessed 27, June 2024.

Nickolich MS, El-Jawahri A, Temel JS, LeBlanc TW. Discussing the Evidence for Upstream Palliative Care in Improving Outcomes in Advanced Cancer. Am Soc Clin Oncol Educ Book. 2016:e534–e538. doi:10.1200/EDBK_159224 PubMed DOI

Global Atlas of Palliative Care at the End of Life; Connor, S.R, Bermedo, M.C.S, Eds.; Worldwide Palliative Care Alliance: London, 2014; ISBN 978-0-9928277-0-0.

Tay RY, Choo RWK, Ong WY, Hum AYM. Predictors of the Final Place of Care of Patients with Advanced Cancer Receiving Integrated Home-Based Palliative Care: a Retrospective Cohort Study. BMC Palliat Care. 2021;20:164. doi:10.1186/s12904-021-00865-5 PubMed DOI PMC

Page R, Blanchard E. Opioids and Cancer Pain: patients’ Needs and Access Challenges. J Oncol Pract. 2019;15(5):229–231. doi:10.1200/JOP.19.00081 PubMed DOI

Smith S, Brick A, O’Hara S, Normand C. Evidence on the Cost and Cost-Effectiveness of Palliative Care: a Literature Review. Palliat Med. 2014;28(2):130–150. doi:10.1177/0269216313493466 PubMed DOI

Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097 PubMed DOI PMC

Leung XY, Sun J, Bai B. Bibliometrics of Social Media Research: a Co-Citation and Co-Word Analysis. Int J Hosp Manag. 2017;66:35–45. doi:10.1016/j.ijhm.2017.06.012 DOI

Zdun-Ryżewska A, Chojnacka-Szawłowska G, Basiński K, Leppert W, Majkowicz M. Cognitive and Emotional Representations of Pain in Cancer Patients at an Inpatient Unit and Home Palliative Care. Curr Probl Cancer. 2019;43(6):100464. doi:10.1016/j.currproblcancer.2019.01.005 PubMed DOI

Swarm RA, Paice JA, Anghelescu DL, et al. Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(8):977–1007. doi:10.6004/jnccn.2019.0038 PubMed DOI

Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: updated Reporting Guidance for Health Economic Evaluations. BMC Med. 2022;20(1):23. doi:10.1186/s12916-021-02204-0 PubMed DOI PMC

Fischer C, Bednarz D, Simon J. Methodological Challenges and Potential Solutions for Economic Evaluations of Palliative and End-of-Life Care: a Systematic Review. Palliat Med. 2024;38(1):85–99. doi:10.1177/02692163231214124 PubMed DOI PMC

Piotrowska W, Leppert W, Majkowicz M. Comparison of Analgesia, Adverse Effects, and Quality of Life in Cancer Patients during Treatment of Procedural Pain with Intravenous Morphine, Fentanyl Nasal Spray, and Fentanyl Buccal Tablets. Cancer Manag Res. 2019;11:1587–1600. doi:10.2147/CMAR.S179012 PubMed DOI PMC

Nosek K, Leppert W, Nosek H, Wordliczek J, Onichimowski D. A Comparison of Oral Controlled-Release Morphine and Oxycodone with Transdermal Formulations of Buprenorphine and Fentanyl in the Treatment of Severe Pain in Cancer Patients. Drug Des Devel Ther. 2017;11:2409–2419. doi:10.2147/DDDT.S141007 PubMed DOI PMC

Cortesi PA, D’Angiolella LS, Vellucci R, et al. Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment. PLoS One. 2017;12(6):e0179523. doi:10.1371/journal.pone.0179523 PubMed DOI PMC

Delibegovic A, Sinanovic O, Galic G, Sabic A, Sabic D. The Influence of Palliative Care on Quality of Life in Patients with Lung Cancer. Mater Socio Medica. 2016;28(6):420. doi:10.5455/msm.2016.28.420-423 PubMed DOI PMC

Ruggeri M, Turriziani A, Oradei M. Cost-Effectiveness Analysis of Transnasal Fentanyl Citrate for the Treatment of Breakthrough Cancer Pain. Expert Rev Pharmacoecon Outcomes Res. 2014;14(3):459–464. doi:10.1586/14737167.2014.904750 PubMed DOI

Leppert W, Zdun-Ryzewska A, Forycka M, Mess E, Majkowicz M. Quality of Life Assessment in Advanced Cancer Patients Treated at Home, an Inpatient Unit, and a Day Care Center. Oncol Targets Ther. 2014;687. doi:10.2147/OTT.S57338 PubMed DOI PMC

Götze H, Brähler E, Gansera L, Polze N, Köhler N. Psychological Distress and Quality of Life of Palliative Cancer Patients and Their Caring Relatives during Home Care. Support Care Cancer. 2014;22(10):2775–2782. doi:10.1007/s00520-014-2257-5 PubMed DOI

Leppert W, Turska A, Majkowicz M, Dziegielewska S, Pankiewicz P, Mess E. Quality of Life in Patients With Advanced Lung Cancer Treated at Home and at a Palliative Care Unit. Am J Hosp Palliat Med. 2012;29(5):379–387. doi:10.1177/1049909111426135 PubMed DOI

Halling CMB, Wolf RT, Sjøgren P, et al. Cost-Effectiveness Analysis of Systematic Fast-Track Transition from Oncological Treatment to Specialised Palliative Care at Home for Patients and Their Caregivers: the DOMUS Trial. BMC Palliat Care. 2020;19(1):142. doi:10.1186/s12904-020-00645-7 PubMed DOI PMC

Maetens A, Beernaert K, De Schreye R, et al. Impact of Palliative Home Care Support on the Quality and Costs of Care at the End of Life: a Population-Level Matched Cohort Study. BMJ Open. 2019;9(1):e025180. doi:10.1136/bmjopen-2018-025180 PubMed DOI PMC

Rowland C, Hanratty B, Pilling M, van den Berg B, Grande G. The Contributions of Family Care-Givers at End of Life: a National Post-Bereavement Census Survey of Cancer Carers’ Hours of Care and Expenditures. Palliat Med. 2017;31(4):346–355. doi:10.1177/0269216317690479 PubMed DOI PMC

Haltia O, Färkkilä N, Roine RP, et al. The Indirect Costs of Palliative Care in End-Stage Cancer: a Real-Life Longitudinal Register- and Questionnaire-Based Study. Palliat Med. 2018;32(2):493–499. doi:10.1177/0269216317729789 PubMed DOI

Brick A, Smith S, Normand C, et al. Costs of Formal and Informal Care in the Last Year of Life for Patients in Receipt of Specialist Palliative Care. Palliat Med. 2017;31(4):356–368. doi:10.1177/0269216316686277 PubMed DOI

Tur-Sinai A, Urban D, Azoulay D, Bar-Sela G, Bentur N. Understanding Out-of-Pocket Spending and Financial Hardship among Patients Who Succumb to Cancer and Their Caregivers. Isr J Health Policy Res. 2022;11(1):1. doi:10.1186/s13584-021-00511-8 PubMed DOI PMC

Kato K, Fukuda H. Comparative Economic Evaluation of Home‐based and Hospital‐based Palliative Care for Terminal Cancer Patients. Geriatr Gerontol Int. 2017;17(11):2247–2254. doi:10.1111/ggi.12977 PubMed DOI

Lustbader D, Mudra M, Romano C, et al. The Impact of a Home-Based Palliative Care Program in an Accountable Care Organization. J Palliat Med. 2017;20(1):23–28. doi:10.1089/jpm.2016.0265 PubMed DOI PMC

Chiang J-K, Kao Y-H. Impact of Home Hospice Care on Patients with Advanced Lung Cancer: a Longitudinal Population-Based Study in Taiwan. J Palliat Med. 2016;19(4):380–386. doi:10.1089/jpm.2015.0278 PubMed DOI

Yu M, Guerriere DN, Coyte PC. Societal Costs of Home and Hospital End-of-Life Care for Palliative Care Patients in Ontario, Canada. Health Soc Care Community. 2015;23(6):605–618. doi:10.1111/hsc.12170 PubMed DOI

Dumont S, Jacobs P, Turcotte V, Turcotte S, Johnston G. Distribution and Sharing of Palliative Care Costs in Rural Areas of Canada. J Palliat Care. 2014;30(2):90–98. doi:10.1177/082585971403000204 PubMed DOI

Chai H, Guerriere DN, Zagorski B, Coyte PC. The Magnitude, Share and Determinants of Unpaid Care Costs for Home-Based Palliative Care Service Provision in Toronto, Canada. Health Soc Care Community. 2014;22:30–39. doi:10.1111/hsc.12058 PubMed DOI

Bentur N, Resnizky S, Balicer R, Eilat-Tsanani T. Utilization and Cost of Services in the Last 6 Months of Life of Patients With Cancer - With and Without Home Hospice Care. Am J Hosp Palliat Med. 2014;31:723–725. doi:10.1177/1049909113499604 PubMed DOI

Curiale V, Cella A, Luzzani M, Prete C. Home-Based Palliative Care for Adults with Cancer. In: Cochrane Database of Systematic Reviews; the Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd; 2007:CD006510.

Kahveci K, Koç O, Aksakal H. Home-Based Palliative Care. Bezmialem Sci. 2020;8(1):73–80. doi:10.14235/bas.galenos.2019.3208 DOI

Kerr CW, Donohue KA, Tangeman JC, et al. Cost Savings and Enhanced Hospice Enrollment with a Home-Based Palliative Care Program Implemented as a Hospice–Private Payer Partnership. J Palliat Med. 2014;17(12):1328–1335. doi:10.1089/jpm.2014.0184 PubMed DOI

Klinger CA, Howell D, Marshall D, Zakus D, Brazil K, Deber RB. Resource Utilization and Cost Analyses of Home-Based Palliative Care Service Provision: the Niagara West End-of-Life Shared-Care Project. Palliat Med. 2013;27(2):115–122. doi:10.1177/0269216311433475 PubMed DOI

Gardiner C, Ryan T, Gott M. What Is the Cost of Palliative Care in the UK? A Systematic Review. BMJ Sup Palliat Care. 2018;8(3):250–257. doi:10.1136/bmjspcare-2018-001519 PubMed DOI

Yadav S, Heller IW, Schaefer N, et al. The Health Care Cost of Palliative Care for Cancer Patients: a Systematic Review. Support Care Cancer. 2020;28(10):4561–4573. doi:10.1007/s00520-020-05512-y PubMed DOI

Gordon MJ, Le T, Lee EW, Gao A. Home Palliative Care Savings. J Palliat Med. 2021;2021:0142. doi:10.1089/jpm.2021.0142 PubMed DOI PMC

Isenberg S, Hsu A, Spruin S, et al. Evaluating the Impact and Costs of Home-Based Palliative Care at the System Level (FR420C). J Pain Symptom Manage. 2019;57(2):410. doi:10.1016/j.jpainsymman.2018.12.122 DOI